Revolutionizing healthcare: the role of artificial intelligence in clinical practice

SA Alowais, SS Alghamdi, N Alsuhebany… - BMC medical …, 2023 - Springer
Introduction Healthcare systems are complex and challenging for all stakeholders, but
artificial intelligence (AI) has transformed various fields, including healthcare, with the …

Deciphering breast cancer: from biology to the clinic

E Nolan, GJ Lindeman, JE Visvader - Cell, 2023 - cell.com
Breast cancer remains a leading cause of cancer-related mortality in women, reflecting
profound disease heterogeneity, metastasis, and therapeutic resistance. Over the last …

[HTML][HTML] Omitting radiotherapy after breast-conserving surgery in luminal A breast cancer

TJ Whelan, S Smith, S Parpia, AW Fyles… - … England Journal of …, 2023 - Mass Medical Soc
Background Adjuvant radiotherapy is prescribed after breast-conserving surgery to reduce
the risk of local recurrence. However, radiotherapy is inconvenient, costly, and associated …

A single-cell and spatially resolved atlas of human breast cancers

SZ Wu, G Al-Eryani, DL Roden, S Junankar, K Harvey… - Nature …, 2021 - nature.com
Breast cancers are complex cellular ecosystems where heterotypic interactions play central
roles in disease progression and response to therapy. However, our knowledge of their …

Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review

S Łukasiewicz, M Czeczelewski, A Forma, J Baj… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is the most common cancer among women. It is estimated
that 2.3 million new cases of BC are diagnosed globally each year. Based on mRNA gene …

Deep learning in cancer diagnosis, prognosis and treatment selection

KA Tran, O Kondrashova, A Bradley, ED Williams… - Genome Medicine, 2021 - Springer
Deep learning is a subdiscipline of artificial intelligence that uses a machine learning
technique called artificial neural networks to extract patterns and make predictions from …

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

LA Huppert, O Gumusay, D Idossa… - CA: a cancer journal for …, 2023 - Wiley Online Library
Hormone receptor (HR)‐positive and human epidermal growth factor receptor 2 (HER2)‐
negative breast cancer is defined by the presence of the estrogen receptor and/or the …

Algorithms to estimate Shapley value feature attributions

H Chen, IC Covert, SM Lundberg, SI Lee - Nature Machine Intelligence, 2023 - nature.com
Feature attributions based on the Shapley value are popular for explaining machine
learning models. However, their estimation is complex from both theoretical and …

Polyamines in cancer: integrating organismal metabolism and antitumour immunity

CE Holbert, MT Cullen, RA Casero Jr… - Nature Reviews …, 2022 - nature.com
The natural mammalian polyamines putrescine, spermidine and spermine are essential for
both normal and neoplastic cell function and replication. Dysregulation of metabolism of …

Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities

X Xu, M Zhang, F Xu, S Jiang - Molecular cancer, 2020 - Springer
Wnt signaling is a highly conserved signaling pathway that plays a critical role in controlling
embryonic and organ development, as well as cancer progression. Genome-wide …